New Research Suggests AREDS2 Supplements May Slow AMD Progression

Age-related macular degeneration (AMD) remains a leading cause of vision loss among older adults worldwide. While the AREDS2 formula has long been a standard recommendation for patients with intermediate AMD, recent research is shedding new light on exactly how these supplements affect the physical structure of the retina. A study presented at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting suggests that these supplements may do more than just lower the risk of progression to advanced stages—they may actually slow the growth of existing lesions.

Understanding the Role of AREDS2

The Age-Related Eye Disease Study 2 (AREDS2) established the efficacy of a specific formulation of vitamins and minerals—including Vitamin C, Vitamin E, zinc, copper, lutein, and zeaxanthin—in reducing the risk of progression to advanced AMD. For years, clinicians have recommended these supplements to patients with intermediate stages of the disease. The recent study, which utilized longitudinal data and AI-driven image analysis, provides a more granular look at how these nutrients influence retinal biomarkers over time.

Key Findings on Retinal Biomarkers

Researchers analyzed 366 patients with intermediate AMD who were advised to take AREDS2 supplements, comparing them against 241 control patients. By using advanced optical coherence tomography (OCT) imaging, the team tracked six specific structural biomarkers associated with lesion growth. The study identified statistically significant reductions in three critical areas for those taking the supplements:

• Hypertransmission defects: A sign of retinal pigment epithelium (RPE) health.
• Complete RPE and outer retinal atrophy: Indicators of tissue thinning and loss.
• Complete ellipsoid zone loss: A marker of photoreceptor health.

These findings suggest that the supplements may help preserve the structural integrity of the retina, potentially slowing the spread of damage that characterizes the progression of dry AMD.

Why This Matters for AMD Patients

For patients living with intermediate AMD, the goal of treatment is the preservation of central vision. While previous studies focused primarily on the risk of transitioning to advanced disease, this research highlights a “disease-modifying” potential. By slowing the expansion of atrophy and lesion growth, patients may be able to maintain visual function for a longer period. The researchers indicated the real-world effect might be even more pronounced, as some patients in the control group may have taken supplements independently, which could have masked more significant differences between the two groups.

Frequently Asked Questions

What is the difference between intermediate and advanced AMD?

Intermediate AMD is typically characterized by the presence of medium-to-large-sized drusen (yellow deposits under the retina) and pigment changes. Advanced AMD involves significant vision loss due to either geographic atrophy (the death of retinal cells) or the growth of abnormal blood vessels (neovascular AMD).

Should all patients with AMD take AREDS2 supplements?

No. The AREDS2 formula is specifically indicated for patients with intermediate AMD or those with advanced AMD in one eye. It is not intended as a preventative measure for individuals without signs of the disease. Always consult your ophthalmologist or retina specialist before starting any supplement regimen, as high doses of certain vitamins can interact with other medications or health conditions.

How does AI improve AMD research?

Artificial Intelligence allows researchers to analyze massive datasets of 2D and 3D retinal images with a level of precision and speed that human review cannot match. In this study, AI helped quantify subtle changes in retinal layers, providing a more objective measurement of how the disease progresses or responds to intervention.

Looking Ahead

While these results are promising, researchers emphasize that some biomarkers may require longer observation periods to fully understand their trajectory. This study reinforces the importance of consistent clinical monitoring and adherence to recommended supplement protocols. As our ability to image the retina becomes more sophisticated, we are gaining a clearer picture of how nutritional interventions can support long-term ocular health.

Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.